Patents by Inventor Jonas Hauser

Jonas Hauser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN MILK OLIGOSACCHARIDES
    Publication number: 20260150874
    Abstract: The present invention relates to 6?-sialyllactose (6?-SL) or compositions comprising 6?-SL for use in promoting visual and auditory function in infant and/or young children. The present invention also relates to the use of 6?-SL or of compositions comprising 6?-SL to promote visual and auditory function in infant and/or young children.
    Type: Application
    Filed: March 22, 2022
    Publication date: June 4, 2026
    Inventors: JONAS HAUSER, WEILI LIN, ZILIANG ZHU, WEIYAN YIN, HONGTU ZHU
  • Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration
    Patent number: 12628857
    Abstract: The present invention relates to a nutritional composition comprising at least one human milk oligosaccharide comprising 3? sialyllactose (3-SL), lacto-N-tetraose (LNT), core-HMOs and any combination thereof for improving improving total night sleep duration in a subject.
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: May 19, 2026
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Clara Lucia Garcia-Rodenas, Jonas Hauser, Weili Lin, Ziliang Zhu, Seoyoon Cho, Tengfei Li
  • Nutritional composition and infant formula for promoting de novo myelination
    Patent number: 12484608
    Abstract: A synthetic nutritional composition containing a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Grant
    Filed: April 16, 2024
    Date of Patent: December 2, 2025
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai, Jonathan O'Regan
  • Human milk oligosaccharides for use in enhancing executive function
    Patent number: 12458052
    Abstract: Use of a human milk oligosaccharide (HMO), or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a non-infant, to prevent and/or reduce the risk of sub-optimal executive function in a non-infant, to manage sub-optimal executive functioning in a non-infant, and/or to improve myelination to mature the pre-frontal cortex region of the brain in a non-infant, as well as synthetic compositions of HMOs and packs comprising at least 14 individual daily doses of an effective amount of at least one HMO for such a use.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: November 4, 2025
    Assignee: Glycom A/S
    Inventors: Bruce McConnell, Louise Kristine Vigsnæs, Jonas Hauser, Nora Schneider
  • COMPOSITIONS AND THEIR USE
    Publication number: 20250280863
    Abstract: A synthetic nutritional composition including folic acid to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Application
    Filed: March 21, 2025
    Publication date: September 11, 2025
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai
  • COMPLEX COACERVATES OF LACTOFERRIN AND OSTEOPONTIN
    Publication number: 20250177491
    Abstract: The present invention relates to a complex coacervate comprising lactoferrin and osteopontin, processes of producing the same and composition comprising the same. Moreover, the present invention relates to complexes comprising lactoferrin and osteopontin in the treatment and/or prevention of metabolic diseases and/or inflammatory diseases. Moreover, the present invention relates to complexes comprising lactoferrin and osteopontin for promoting bone development, growth, strength and/or healing, or preventing and/or treating a bone disease.
    Type: Application
    Filed: February 21, 2023
    Publication date: June 5, 2025
    Inventors: MARIE NOELLE HORCAJADA, NICOLAS BONNET, JONAS HAUSER
  • COMPLEX COACERVATES OF LACTOFERRIN AND OSTEOPONTIN
    Publication number: 20250066454
    Abstract: The present invention relates to a complex coacervate comprising lactoferrin and osteopontin, processes of producing the same and composition comprising the same. Moreover, the present invention relates to complexes comprising lactoferrin and osteo-pontin in the treatment and/or prevention of metabolic diseases and/or inflammatory diseases. Moreover, the present invention relates to complexes comprising lactoferrin and osteopontin for promoting bone development, growth, strength and/or healing, or preventing and/or treating a bone disease.
    Type: Application
    Filed: December 16, 2022
    Publication date: February 27, 2025
    Inventors: DAVID GOULDING, JONATHAN O'REGAN, LIONEL JEAN RENE BOVETTO, KARINE VIDAL, MARIE NOELLE HORCAJADA, NICOLAS BONNET, JONAS HAUSER
  • NUTRITIONAL COMPOSITION AND INFANT FORMULA FOR PROMOTING DE NOVO MYELINATION
    Publication number: 20240349771
    Abstract: A synthetic nutritional composition containing a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Application
    Filed: April 16, 2024
    Publication date: October 24, 2024
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai, Jonathan O'Regan
  • Nutritional composition and infant formula for promoting de novo myelination
    Patent number: 11986003
    Abstract: A synthetic nutritional composition comprising a phospholipid and/or a metabolic precursor and/or metabolite thereof for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential, and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Grant
    Filed: February 23, 2022
    Date of Patent: May 21, 2024
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai, Jonathan O'Regan
  • Nutritional composition and infant formula for promoting myelination of the brain
    Patent number: 11986445
    Abstract: A synthetic nutritional composition comprising choline for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: May 21, 2024
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai
  • Nutritional composition and infant formula for promoting myelination of the brain
    Patent number: 11930836
    Abstract: A synthetic nutritional composition comprising a fatty acid derivative for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: March 19, 2024
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai
  • HUMAN MILK OLIGOSACCHARIDES FOR USE IN SUPPORTING MATURATION OR IMPROVEMENT OF SLEEPING PATTERNS
    Publication number: 20240024343
    Abstract: The present invention relates to fucosylated human milk oligosaccharides for improving sleep maturation, for example improving trouble sleeping, in a non-infant.
    Type: Application
    Filed: December 3, 2021
    Publication date: January 25, 2024
    Inventors: Ingvild Dybdrodt ADMUNSEN, Clara Lucia GARCIA-RODENAS, Jonas HAUSER
  • Nutritional composition for use to enhance attention and/or reduce impulsivity
    Patent number: 11872238
    Abstract: Use of a sialyllactose, or a nutritional composition comprising a sialyllactose, to enhance attention and/or to decrease impulsivity in a subject.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: January 16, 2024
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Jonas Hauser, Simone Macri
  • COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN A SUBJECT TO SUPPORT MATURATION OF SLEEPING PATTERNS
    Publication number: 20240000818
    Abstract: The present invention relates to a nutritional composition comprising fucosylated human milk oligosaccharides for improving sleep maturation in a subject.
    Type: Application
    Filed: December 3, 2021
    Publication date: January 4, 2024
    Inventors: CLARA LUCIA GARCIA-RODENAS, JONAS HAUSER
  • COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN A SUBJECT TO SUPPORT NIGHT SLEEP DURATION
    Publication number: 20240000122
    Abstract: The present invention relates to a nutritional composition comprising at least one human milk oligosaccharide comprising 3? sialyllactose (3-SL), lacto-N-tetraose (LNT), core-HMOs and any combination thereof for improving improving total night sleep duration in a subject.
    Type: Application
    Filed: December 3, 2021
    Publication date: January 4, 2024
    Inventors: CLARA LUCIA GARCIA-RODENAS, JONAS HAUSER, WEILI LIN, ZILIANG ZHU, SEOYOON CHO, TENGFEI LI
  • COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN A SUBJECT TO SUPPORT LANGUAGE DEVELOPMENT
    Publication number: 20230013403
    Abstract: The present invention relates to a nutritional composition comprising at least one human milk oligosaccharide comprising 3? sialyllactose (3-SL), 6? sialyllactose (6-SL), 3-fucosyllactose and any combination thereof for improving language development in a subject, preferably born from a A-tetrasaccharide positive mother and/or the subject fed with a mother's milk rich in A-tetrasaccharide
    Type: Application
    Filed: December 7, 2020
    Publication date: January 19, 2023
    Inventors: MANJIANG YAO, JIAN YAN, JONAS HAUSER, WEILI LIN, DI WU, TENGFEI LI, ZILIANG ZHU, SEOYOON CHO
  • NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION
    Publication number: 20230015563
    Abstract: A synthetic nutritional composition comprising a mineral for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Application
    Filed: September 13, 2022
    Publication date: January 19, 2023
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai
  • COMPOSITIONS AND THEIR USE
    Publication number: 20220378078
    Abstract: A synthetic nutritional composition comprising a vitamin for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Application
    Filed: April 15, 2022
    Publication date: December 1, 2022
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai
  • Nutritional compositions and infant formula for promoting de novo myealination
    Patent number: 11478011
    Abstract: A synthetic nutritional composition comprising a mineral for use to promote, support or optimise de novo myelination, in particular the de novo myelination trajectory, and/or brain structure, and/or brain connectivity, and/or intellectual potential and/or cognitive potential and/or learning potential and/or cognitive functioning in a subject, in particular a formula fed subject.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: October 25, 2022
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Nora Schneider, Jonas Hauser, Sean Deoni, Tamas Bartfai
  • A NUTRITIONAL COMPOSITION FOR USE TO ENHANCE EXECUTIVE FUNCTION
    Publication number: 20220225627
    Abstract: Use of a human milk oligosaccharide, or a nutritional composition comprising a human milk oligosaccharide, to enhance executive function in a subject.
    Type: Application
    Filed: March 5, 2020
    Publication date: July 21, 2022
    Inventors: Jonas Hauser, Nora Schneider